From the Desk of Dr. Kent
Get the lastest news on TMS therapy and find out what NuMe TMS is up to now.
BrainsWay, a leading global provider of advanced noninvasive neurostimulation treatments for mental health disorders, has recently published three significant articles showcasing the benefits of its Deep Transcranial Magnetic Stimulation (Deep TMS™) technology. These publications delve into the safety profile of TMS, offering insights from comprehensive trials involving H1, H4, and H7 Coils. They also address the practical challenges of performing TMS on patients with metallic implants.
Additionally, BrainsWay's research highlights the efficacy of Deep TMS in treating smoking addiction, with potential applications for alcohol and other substance use disorders. BrainsWay's commitment to rigorous scientific exploration, exemplified by its Vice President of Medical Affairs, Colleen Hanlon, reinforces the company's dedication to improving mental health treatment.
Operating at the forefront of neuroscience, BrainsWay has obtained three FDA-clearances supported b
A global medical technology company, BrainsWay focuses on developing cutting-edge medical devices that help advance the field of mental healthcare. Our advanced flagship technology of Deep Transcranial Magnetic Stimulation (Deep TMS™) is expanding the treatment of mental health beyond what was thought possible.
Deep TMS treatment has been proven to offer significant results by directly stimulating deeper and broader areas of the brain, effectively treating conditions such as depression, anxious depression, obsessive-compulsive disorder, and smoking addiction.
With numerous clinical studies and a growing number of patients and healthcare providers attesting to its success, BrainsWay Deep TMS is boldly advancing the treatment of mental health disorders.
Click the link for more information:
https://www.brainsway.com